Literature DB >> 21816191

Transgenic Neospora caninum strains constitutively expressing the bradyzoite NcSAG4 protein proved to be safe and conferred significant levels of protection against vertical transmission when used as live vaccines in mice.

V Marugán-Hernández1, L M Ortega-Mora, A Aguado-Martínez, E Jiménez-Ruíz, G Alvarez-García.   

Abstract

At present, there is no effective treatment or vaccine to prevent vertical transmission or abortion associated with Neospora caninum infection in cattle. Different vaccine formulations have been assayed, and live vaccines have shown the most promising results in terms of protection. Previously, transgenic N. caninum tachyzoites expressing the bradyzoite stage-specific NcSAG4 antigen in a constitutive manner (Nc-1 SAG4(c)) were obtained and showed a reduced persistence of parasite in inoculated mice. Thus, the present study evaluates the Nc-1 SAG4(c)1.1 and Nc-1 SAG4(c)2.1 transgenic strains and the Nc-1 wild-type (WT) strain to determine their protective efficacy against vertical transmission and cerebral neosporosis in mice. Consequently, dams were immunized twice with 5 × 10(5) tachyzoites of each strain and challenged with 2 × 10(6) tachyzoites of a heterologous and virulent isolate at 7-10 days of gestation. The Nc-1 SAG4(c)1.1 strain offered less protection than the other transgenic strain (Nc-1 SAG4(c)2.1) or their ancestor (Nc-1 WT). Indeed, 40%, 7% and 5.6% of the postnatal deaths corresponded to pups from dams vaccinated with Nc-1 SAG4(c)1.1, Nc-1 SAG4(c)2.1 and Nc-1 (WT) strains, respectively. In comparison, the non-immunized challenge group had a 100% mortality rate. In addition, mice were protected against congenital transmission; vertical transmission rates were 45%, 11.1% and 10.8% in the Nc-1 SAG4(c)1.1, Nc-1 SAG4(c)2.1 and Nc-1 WT immunized groups, respectively, vs. 94.9% in the non-vaccinated infected group. However, this protection against the postnatal mortality and the vertical transmission was not associated with a consistent Th1 or Th2-type immune response. Nonetheless, the Nc-1 SAG4(c)2.1 strain appears to be the best candidate for use as a live vaccine, as evidenced by results demonstrating its high levels of protection against vertical transmission and its lower persistence in mice, making this transgenic strain safer than Nc-1 WT.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21816191     DOI: 10.1016/j.vaccine.2011.07.091

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Comparative study of protective activities of Neospora caninum bradyzoite antigens, NcBAG1, NcBSR4, NcMAG1, and NcSAG4, in a mouse model of acute parasitic infection.

Authors:  Masaki Uchida; Kotomi Nagashima; Yui Akatsuka; Takashi Murakami; Akira Ito; Soichi Imai; Kazunori Ike
Journal:  Parasitol Res       Date:  2012-11-15       Impact factor: 2.289

2.  New molecular tools in Neospora caninum for studying apicomplexan parasite proteins.

Authors:  Caroline M Mota; Allan L Chen; Kevin Wang; Santhosh Nadipuram; Ajay A Vashisht; James A Wohlschlegel; Tiago W P Mineo; Peter J Bradley
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379

3.  Immune Protective Evaluation Elicited by DNA Vaccination With Neospora caninum Dense Granules Proteins in Mice.

Authors:  Guili Yu; Wei Liang; Qiankun Yang; Jinxin Wang; Yu Wang; Tianmeng Zhang; Xiao Zhang; Hui Fan; Panpan Zhao; Lili Cao; Jingquan Dong
Journal:  Front Vet Sci       Date:  2021-02-26

4.  A Listeria monocytogenes-Based Vaccine Formulation Reduces Vertical Transmission and Leads to Enhanced Pup Survival in a Pregnant Neosporosis Mouse Model.

Authors:  Dennis Imhof; William Robert Pownall; Camille Monney; Anna Oevermann; Andrew Hemphill
Journal:  Vaccines (Basel)       Date:  2021-11-26

5.  Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice.

Authors:  Silvia Rojo-Montejo; Esther Collantes-Fernández; Inmaculada López-Pérez; Verónica Risco-Castillo; Antoni Prenafeta; Luis Miguel Ortega-Mora
Journal:  Vet Res       Date:  2012-08-22       Impact factor: 3.683

6.  Effect of vaccination of cattle with the low virulence Nc-Spain 1H isolate of Neospora caninum against a heterologous challenge in early and mid-gestation.

Authors:  Silvia Rojo-Montejo; Esther Collantes-Fernández; Francisco Pérez-Zaballos; Sonia Rodríguez-Marcos; Javier Blanco-Murcia; Antonio Rodríguez-Bertos; Antoni Prenafeta; Luis Miguel Ortega-Mora
Journal:  Vet Res       Date:  2013-11-01       Impact factor: 3.683

7.  The Impact of BKI-1294 Therapy in Mice Infected With the Apicomplexan Parasite Neospora caninum and Re-infected During Pregnancy.

Authors:  Pablo Winzer; Dennis Imhof; Nicoleta Anghel; Dominic Ritler; Joachim Müller; Ghalia Boubaker; Adriana Aguado-Martinez; Luis-Miguel Ortega-Mora; Kayode K Ojo; Wesley C VanVoorhis; Andrew Hemphill
Journal:  Front Vet Sci       Date:  2020-10-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.